X4 Pharmaceuticals (XFOR) Return on Capital Employed Growth (1y) (2019 - 2026)
X4 Pharmaceuticals (XFOR) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -1,490.00 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,629.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.41 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -310.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3,193.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 399.00 |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn | 7,465.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,465.00 |
| Dec 31, 2025 | -1,505.00 |
| Sep 30, 2025 | -7,354.00 |
| Jun 30, 2025 | -9,779.00 |
| Mar 31, 2025 | 10,117.00 |
| Dec 31, 2024 | 5,012.00 |
| Sep 30, 2024 | 5,727.00 |
| Jun 30, 2024 | 6,558.00 |
| Mar 31, 2024 | -2,945.00 |
| Dec 31, 2023 | -18.00 |
| Sep 30, 2023 | 5,997.00 |
| Jun 30, 2023 | 5,213.00 |
| Mar 31, 2023 | 1,533.00 |
| Dec 31, 2022 | 312.00 |
| Sep 30, 2022 | -7,038.00 |
| Jun 30, 2022 | -7,997.00 |
| Mar 31, 2022 | -4,184.00 |
| Dec 31, 2021 | -2,960.00 |
| Sep 30, 2021 | -1,995.00 |
| Jun 30, 2021 | -1,312.00 |